Sökning: id:"swepub:oai:DiVA.org:oru-109203" >
COVID-19 Pandemic's...
-
Trindade, Inês A.,1990-Center for Research in Neuropsychology and Cognitive and Behavioral Intervention (CINEICC), Faculty of Psychology and Education Sciences, University of Coimbra, Coimbra, Portugal
(författare)
COVID-19 Pandemic's Effects on Disease and Psychological Outcomes of People with Inflammatory Bowel Disease in Portugal : A Preliminary Research
- Artikel/kapitelEngelska2021
Förlag, utgivningsår, omfång ...
-
2020-10-12
-
Oxford University Press,2021
-
printrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:oru-109203
-
https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-109203URI
-
https://doi.org/10.1093/ibd/izaa261DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Aims: No empirical research on the psychological impact of the coronavirus disease 2019 (COVID-19) pandemic on people living with IBD, a population known to typically present high levels of anxiety and depression and to be potentially vulnerable to COVID-19, has yet been conducted. This study aimed to explore the links between contextual variables related to the COVID-19 pandemic and disease and psychological outcomes.Methods: The sample included 124 Portuguese patients with Crohn's disease or ulcerative colitis (85.48% women) who completed self-reported measures in an online survey during April 2020.Results: Fear of contracting COVID-19 and medication adherence were both high and unrelated. About half of the sample presented moderate (37.10%) to severe (14.50%) anxiety. Normal and mild anxiety levels were at 29.80% and 18.50%, respectively. Regarding depressive symptoms, 51.60% of the sample presented normal levels, 27.40% mild severity, 16.10% moderate, and 4.8% severe. No differences were found between Crohn's disease and ulcerative colitis patients. Regression analyses showed that anxiety explained IBD symptom perception (beta = 0.29; P = 0.022); fear of contracting COVID-19 (beta = 0.35; P < 0.001) and IBD symptom perception (beta = -0.22; P = 0.009) explained depressive symptoms; and fear of contracting COVID-19 (beta = 0.41; P < 0.001), IBD symptom perception (beta = 0.26, P < 0.001), and being in isolation (beta = -0.16, P = 0.041) explained anxiety. Type of medication was not linked to these outcomes.Conclusions: The COVID-19 pandemic does not seem to he affecting adherence to medication but seems to present relevant effects on psychological well-being. Inflammatory bowel disease health care professionals should be attentive of patients' psychological response to this pandemic and of its possible consequences on disease expression. This study additionally provided a psychometrically sound measure of fear of contracting COVID-19.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Ferreira, Nuno B.University of Nicosia, Cyprus
(författare)
-
Center for Research in Neuropsychology and Cognitive and Behavioral Intervention (CINEICC), Faculty of Psychology and Education Sciences, University of Coimbra, Coimbra, PortugalUniversity of Nicosia, Cyprus
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Inflammatory Bowel Diseases: Oxford University Press27:8, s. 1224-12291078-09981536-4844
Internetlänk
Hitta via bibliotek
Till lärosätets databas